Associated Papers
Surfactant Protein (SP)-A Benefits Over SP-A Mutant: A Preliminary Study for Interstitial Lung Disease Treatment.
Desroziers T et al.
American Journal of Respiratory Cell and Molecular Biology, 2025
40591931 (PubMed )
Supplement: desroziers_data_supplement.pdf
A Test to Comprehensively Capture the Known Genetic Component of Familial Pulmonary Fibrosis.
Villeneuve J et al.
American Journal of Respiratory Cell and Molecular Biology, 2024
Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer.
Legendre M et al.
The European Respiratory Journal, 2020
Identification and functional characterization of a novel surfactant protein A2 mutation (p.N207Y) in a Chinese family with idiopathic pulmonary fibrosis.
Liu L et al.
Molecular Genetics & Genomic Medicine, 2020
SFTPA2 Mutations in Familial and Sporadic Idiopathic Interstitial Pneumonia.
van Moorsel CH et al.
American Journal of Respiratory and Critical Care Medicine, 2015
Select a paper to view details